← All Articles

NSEL Settlement Scheme: Lessons for Unlisted Investors

SEBI just closed proceedings against 91 brokers via the NSEL settlement scheme. Here is what private market investors must learn about counterparty risk.

What the NSEL Settlement Scheme Really Tells Us

Regulators move slowly, but they rarely forget. Over a decade after the National Spot Exchange Limited imploded in 2013, the capital markets regulator has closed proceedings against 91 commodity brokers. The vehicle? The SEBI NSEL settlement scheme, a mechanism designed to let intermediaries clear their names by paying specified charges without admitting or denying guilt.

For anyone who held contracts back in July 2013, the memory is painful. Roughly Rs 5,600 crore in investor capital froze overnight when paired contracts on the exchange turned out to have little or no physical commodity backing them up in the warehouses.

Most people reading financial pages will treat this settlement as an old chapter finally closing. That is a mistake.

If you allocate capital into private markets, unlisted debt, or high-yield structured notes, the resolution of these proceedings carries an urgent lesson. It exposes what happens when counterparty diligence fails, when marketing labels disguise structural leverage, and when investors confuse institutional branding with actual settlement security.

The Anatomy of an Institutional Blind Spot

To see why the NSEL episode still matters, look at how those products were sold in 2012 and 2013.

Brokers marketed paired contracts as risk-free arbitrage. An investor bought a T+2 contract (settling in two days) and simultaneously sold a T+25 or T+36 contract at a fixed premium. The annualized return sat neatly between 13% and 15%. Wealth desks pitch these numbers all the time. On paper, it looked like money-market paper with a corporate-debt yield.

Except the mechanics were hollow:

  • The underlying borrowers were a tiny cluster of processors who borrowed money against pledged agricultural stock.
  • The exchange never verified that the physical commodities existed in the warehouses to match the trade volume.
  • The brokers took significant commissions while failing to run basic independent checks on whether warehouse receipts were authentic.
  • Investors assumed the clearing corporation held bulletproof default guarantees. It did not.

When the music stopped, 13,000 investors discovered their "risk-free fixed income" was actually unsecured credit to a handful of balance sheets.

Now, through the NSEL settlement scheme, intermediaries are closing their regulatory books. But the capital recovery for the original end-investors remains fractional, dragged through years of litigation across the Bombay High Court and specialized tribunals.

Private Markets and Counterparty Blindness Today

Consider the private markets in India today. Retail and high-net-worth participation in unlisted shares and late-stage startups has grown dramatically over the past four years. Platforms have popped up everywhere, letting anyone buy shares of upcoming unicorns with a few clicks.

That access is a good development. But it introduces familiar operational vulnerabilities.

When you buy listed equities on the NSE or BSE, you have a qualified clearing corporation standing between you and the seller. Settlement happens via T+1 netting, governed by depository mechanics that make counterparty default almost impossible for retail trades.

In unlisted equity transactions, off-market transfers, and bilateral structured credit, you step outside that safety net.

If you purchase unlisted tech stock from an intermediary, where are the shares coming from? Are they being delivered from a verified depository participant account directly to your demat, or are you entering into a secondary contract with a synthetic settlement window?

These questions sound pedantic right up until a transaction breaks.

Listed Market Safeguards vs. Over-the-Counter Transactions

+----------------------+---------------------------+---------------------------+
| Feature              | Listed Equities (NSE/BSE) | Off-Market / Unlisted     |
+----------------------+---------------------------+---------------------------+
| Counterparty Risk    | Cleared by NSCCL/ICCL     | Bilateral (Seller/Broker) |
| Settlement Window    | T+1 rolling               | Variable (T+0 to T+7)     |
| Asset Verification   | Real-time electronic      | Pre-transfer demat proof  |
| Pricing Discovery    | Public order book         | Dealer quotes / Off-board |
+----------------------+---------------------------+---------------------------+

Three Hidden Risks HNIs Overlook in Private Assets

Private asset allocation requires higher skepticism than public market buying. The resolution via the NSEL settlement scheme highlights three specific vulnerabilities that every portfolio manager needs to audit.

1. The Intermediary Trust Trap

In the spot exchange mess, clients trusted their relationship managers. The relationship managers trusted their research desks. The research desks trusted the exchange's circulars. Nobody checked the physical sheds in Maharashtra or Gujarat.

In private deals, never rely on an intermediary's summary deck alone. If you are buying pre-IPO inventory, confirm the precise legal entity holding the shares. Are they owned free of liens? Is there a pending board approval or right of first refusal (ROFR) from existing institutional backers that could invalidate the transfer? Demand the client master report (CMR) copies and verify the ISIN directly on NSDL or CDSL.

2. Illiquidity Disguised as Stability

Unlisted shares do not mark to market every minute. That lack of price volatility creates a psychological illusion: the asset feels stable.

In reality, illiquidity is a multiplier of structural risk. If operational or governance issues emerge inside a private issuer, you cannot place a market sell order at 9:16 AM. You are locked in. When assessing off-market opportunities, always price in an illiquidity premium. If a listed comparable trades at 30 times earnings, an unlisted peer with weaker reporting should rarely be bought at the same multiple without clear strategic upside.

3. Jurisdictional and Regulatory Arbitrage

The 2013 crisis slipped through the cracks because the spot exchange operated under exemptions granted by the Ministry of Consumer Affairs, falling outside the direct oversight of the Forward Markets Commission at the time.

Watch for similar regulatory seams today. Whether evaluating overseas venture funds, cross-border remittance plays, or digital assets, ask yourself: Which regulator steps in if this entity goes dark tomorrow?

This is why many Indian family offices now structure international allocations through transparent, highly regulated corridors. Using the IFSC framework at GIFT City for global investing ensures trades operate under clean regulatory supervision from the IFSCA, rather than unregulated overseas holding companies.

Due Diligence Checklist for Private Share Transfers

Before you wire capital for any private equity secondary or off-market placement, run this basic operational filter:

  • Verify the ISIN and Share Class: Ensure the shares being transferred match the exact class you analyzed. Founders and early funds often hold preference shares with liquidation preferences; secondary buyers typically receive equity shares without those protections.
  • Delivery Versus Payment (DVP): Never send funds to an unverified third-party account on a promise of future share credit. Professional desks execute through escrow mechanisms or clean simultaneous clearing windows.
  • Tax Withholding Clearances: Check whether the transferor has cleared capital gains obligations, especially if buying secondary shares from an overseas entity or non-resident.
  • Lock-in Realities: SEBI regulations mandate specific statutory lock-in periods for pre-IPO shares once a draft red herring prospectus (DRHP) matures into an actual listing. Ensure your liquidity horizon accounts for minimum post-listing lock-ins.

You can run these scenarios through our investor tools to see how transaction costs, holding periods, and liquidity discounts hit your net internal rate of return.

The Long View on Market Integrity

The closure brought by the NSEL settlement scheme shows that the regulatory perimeter eventually catches up with past operational failures. But a regulatory settlement years down the road is cold comfort for capital that sat frozen or evaporated.

Smart wealth creation is fundamentally an exercise in risk management. Finding great companies before they hit public exchanges offers outsized growth, but that upside is only real if the mechanics under the hood are completely sound.

If you are structuring allocations across off-market counters, pre-IPO opportunities, or global structures, take counterparty review seriously. Independent verification costs very little; skipped diligence costs everything.

If you want to review your private market holdings, audit counterparty exposure, or evaluate clean institutional channels for late-stage assets, talk to an advisor at Neoma Capital or book a call with our private assets team.

Frequently Asked Questions

What was the NSEL settlement scheme?

The NSEL settlement scheme was introduced by SEBI to resolve long-standing regulatory proceedings against commodity brokers involved in the 2013 National Spot Exchange Limited crisis. It allowed brokers facing scrutiny over paired contracts to settle violations by paying a calculated settlement amount without admitting or denying the findings.

How does counterparty risk differ in unlisted shares versus listed equities?

In listed equities, counterparty risk is cleared by registered clearing corporations that guarantee settlement. In unlisted shares, transactions are typically bilateral, meaning you face the direct risk of whether the seller actually holds the shares free of encumbrance and whether the broker executes the demat transfer correctly.

Can unlisted shares be held safely in an ordinary demat account?

Yes. Once unlisted shares are successfully transferred, they sit inside your regular CDSL or NSDL demat account under their designated ISIN alongside your listed holdings. The risk in unlisted markets lies primarily in the execution and settlement phase prior to the shares hitting your account.


This is educational content, not investment advice. Investments in securities are subject to market risks.

Talk to Neoma Capital

Get today's unlisted & pre-IPO price list

Live indicative prices for 500+ unlisted shares, plus a free call with a CA advisor. No spam, no obligation.

Send me the price list

Free · on WhatsApp · one CA advisor will follow up.

Trusted by 15,000+ investors · your details are never shared.

Found this useful? Share it

About the Author

Neoma Research produces institutional grade research across Indian and global markets. For research enquiries or to request a bespoke report, write to research@neomacapital.com.

Want Personalised Advisory?

Our team provides one-on-one advisory calls for HNIs and family offices.

Book a Free Call
LinkedInEmail UsChat with us